Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-02-09

FDA Approved: SUMATRIPTAN — Original Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)

View source ↗

Summary

FDA approves Sun Pharmaceutical Industries' original application for Sumatriptan (oral tablet), a generic treatment for acute migraine in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan (Sumatriptan)

Snippet

ORIG AP for SUMATRIPTAN (SUMATRIPTAN)